Arkolith/Insider Trading/GNLX/Form 4

Yu Yong

SVP, Clinical DevelopmentGENELUX Corp (GNLX) · full profile →Form 4 · filed Sep 3, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
0 non-derivative · 4 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 1, 2025Grant(A)65K——65K
Sep 1, 2025Disposed to issuer(D)65K——0
Sep 1, 2025Grant(A)208K——208K
Sep 1, 2025Disposed to issuer(D)208K——0

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001641172-25-026397) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML